Camber Recalls Oxycodone 15mg Tablets Due to Labeling Error
Camber Pharmaceuticals recalls 45,875 bottles of 15mg Oxycodone tablets because the label is missing the required CII controlled substance symbol.
Use caution until it’s fixed
Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol
Contact the company
What happened, in plain English
Camber Pharmaceuticals has recalled specific lots of Oxycodone Hydrochloride Tablets, USP 15 mg, manufactured by Ascent Pharmaceuticals. The issue is a labeling error where the bottles are missing the mandatory Class II (CII) controlled substance symbol. This affects approximately 45,875 bottles distributed nationwide. Read more at govinfonow.com/recall/40911-camber-recalls-oxycodone-15mg-tablets-due-to-labeling-error.
Source Summary by GovInfoNow · govinfonow.com/recall/40911-camber-recalls-oxycodone-15mg-tablets-due-to-labeling-error · Updated October 11, 2026 · FDA enforcement record: FDA #D-0248-2018
Cite this page
“Camber Recalls Oxycodone 15mg Tablets Due to Labeling Error.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/40911-camber-recalls-oxycodone-15mg-tablets-due-to-labeling-error. Based on FDA recall #D-0248-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0248-2018%22&limit=1).
Why it’s dangerous
The primary hazard is regulatory non-compliance rather than immediate physical injury. The missing CII symbol means the label fails to properly identify the drug as a controlled substance, which can lead to confusion regarding storage, handling, and legal requirements for prescription medications.
Who’s affected
Patients who have been prescribed Oxycodone Hydrochloride Tablets, USP 15 mg from the affected lots and purchased them anywhere in the United States. These individuals may possess medication that does not clearly indicate its status as a controlled substance on the packaging.
How to tell if you have this one
Check your bottle of Oxycodone Hydrochloride Tablets, USP 15 mg for the following details. Look for NDC 31722-917-01 and verify if any of these lot numbers are present: 17080591 (exp 07/19), 17080619 (exp 07/19), 17110907 (exp 10/19), 17110908 (exp 10/19), or 17120986 (exp 11/19). Ensure the bottle is manufactured by Ascent Pharmaceuticals, Inc. for Camber Pharmaceuticals, Inc.
- Brand
Camber Pharmaceuticals- Category
Drug
What to do — step by step
Check Your Bottle
Verify if your Oxycodone Hydrochloride Tablets match the NDC and lot numbers listed in the recall record.
Contact Your Pharmacist
If you have one of the affected bottles, contact your pharmacy or healthcare provider for instructions on how to return or dispose of the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0248-2018 (January 22, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0248-2018 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.